Xvivo Perfusion AB - Asset Resilience Ratio

Latest as of December 2025: 12.30%

Xvivo Perfusion AB (XVIVO) has an Asset Resilience Ratio of 12.30% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr292.09 Million

≈ $31.43 Million USD Cash + Short-term Investments

Total Assets

Skr2.37 Billion

≈ $255.49 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Xvivo Perfusion AB's Asset Resilience Ratio has changed over time. Check Xvivo Perfusion AB PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Xvivo Perfusion AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Xvivo Perfusion AB market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr292.09 Million	12.3%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr292.09 Million	12.30%

Asset Resilience Insights

Moderate Liquidity: Xvivo Perfusion AB has 12.30% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Xvivo Perfusion AB Industry Peers by Asset Resilience Ratio

Compare Xvivo Perfusion AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Edwards Lifesciences Corp NYSE:EW	Medical Devices	9.20%
DexCom Inc NASDAQ:DXCM	Medical Devices	19.55%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A SHG:688212	Medical Devices	6.09%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Corentec Co Ltd KQ:104540	Medical Devices	2.80%
Adherium Ltd AU:ADR	Medical Devices	15.45%

Annual Asset Resilience Ratio for Xvivo Perfusion AB (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Xvivo Perfusion AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.30%	Skr292.09 Million ≈ $31.43 Million	Skr2.37 Billion ≈ $255.49 Million	-4.98pp
2024-12-31	17.28%	Skr415.22 Million ≈ $44.68 Million	Skr2.40 Billion ≈ $258.57 Million	-21.25pp
2023-12-31	38.54%	Skr846.09 Million ≈ $91.05 Million	Skr2.20 Billion ≈ $236.28 Million	+20.19pp
2022-12-31	18.34%	Skr317.86 Million ≈ $34.21 Million	Skr1.73 Billion ≈ $186.51 Million	-7.51pp
2021-12-31	25.85%	Skr398.70 Million ≈ $42.91 Million	Skr1.54 Billion ≈ $166.01 Million	-4.95pp
2020-12-31	30.79%	Skr354.24 Million ≈ $38.12 Million	Skr1.15 Billion ≈ $123.79 Million	+5.59pp
2019-12-31	25.21%	Skr159.95 Million ≈ $17.21 Million	Skr634.49 Million ≈ $68.28 Million	-6.68pp
2018-12-31	31.89%	Skr187.06 Million ≈ $20.13 Million	Skr586.61 Million ≈ $63.13 Million	-4.38pp
2017-12-31	36.27%	Skr195.32 Million ≈ $21.02 Million	Skr538.54 Million ≈ $57.96 Million	+29.15pp
2016-12-31	7.12%	Skr24.87 Million ≈ $2.68 Million	Skr349.30 Million ≈ $37.59 Million	--

pp = percentage points

About Xvivo Perfusion AB

ST:XVIVO Sweden Medical Devices

Market Cap

$894.24 Million

Skr8.31 Billion SEK

Market Cap Rank

#9226 Global

#146 in Sweden

Share Price

Skr263.80

Change (1 day)

+1.15%

52-Week Range

Skr160.80 - Skr305.20

All Time High

Skr539.00